CRYSTAL YAMADA: Open Payments
NPI 1942893086 · MAKAWAO, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,739 in 50 payments from 11 companies in 2025. Trend: 2023 $879 · 2024 $1,970 · 2025 $1,739
Food & beverage: $1,630Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $397 |
| Regeneron Healthcare Solutions, Inc. | 6 | $344 |
| Arcutis Biotherapeutics, Inc. | 3 | $230 |
| Galderma Laboratories, L.P. | 4 | $223 |
| Lilly USA, LLC | 6 | $153 |
| LEO Pharma Inc. | 6 | $148 |
| E.R. Squibb & Sons, L.L.C. | 2 | $100 |
| UCB, Inc. | 1 | $42 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $42 |
| GENZYME CORPORATION | 1 | $36 |
Products named: DUPIXENT, SKYRIZI, Zoryve, NEMLUVIO, TALTZ, ADBRY, Sotyktu, Bimzelx.
Industry payments across HI — which companies pay providers there.
